7459 — Medipal Holdings Income Statement

0.000.00%

Last trade - 00:00

HealthcareConservativeLarge CapSuper Stock

Annual income statement for Medipal Holdings, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.

	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st	2026 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Yuho	Yuho	Yuho	Yuho	Tanshin
Standards:	JAS	JAS	JAS	JAS	—
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	3,290,921	3,360,008	3,558,732	3,671,328	3,817,354
Cost of Revenue
Gross Profit	217,445	224,305	246,655	255,759	260,988
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	3,250,430	3,318,994	3,509,827	3,615,837	3,779,217
Operating Profit	40,491	41,014	48,905	55,491	38,137
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	57,284	70,061	74,741	76,734	81,844
Provision for Income Taxes
Net Income After Taxes	39,197	48,323	51,768	51,531	53,141
Minority Interest
Net Income Before Extraordinary Items
Net Income	29,425	38,806	41,475	40,281	42,535
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income	29,320	38,752	41,474	40,279	42,534
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	148	206	196	201	277
Dividends per Share